Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Juventas)"
Count: 16
Selected: 0
| NCT ID | Title |
|---|
| NCT04684147 | Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia | ||
| NCT04586478 | Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma | ||
| NCT04232826 | A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma | ||
| NCT04230473 | A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia | ||
| NCT02544204 | SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease | ||
| NCT02115568 | Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203 | ||
| NCT01961726 | Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure | ||
| NCT01643590 | Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. | ||
| NCT01410331 | Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia | ||
| NCT01082094 | Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure | ||
| NCT04690192 | CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma | ||
| NCT04034446 | CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL) | ||
| NCT04011293 | A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies | ||
| NCT04008524 | A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies | ||
| NCT03029338 | CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma | ||
| NCT02975687 | CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia |
